These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 5150312)

  • 1. [A case of icterus in the course of treatment with rifampicin. Histological records].
    Laroche C; Caquet R; Desche-Labarthe S; Fraisse B; Lemaigre G
    Ann Med Interne (Paris); 1971 Nov; 122(11):1119-22. PubMed ID: 5150312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin hepatitis. A clinical and histological study.
    Scheuer PJ; Summerfield JA; Lal S; Sherlock S
    Lancet; 1974 Mar; 1(7855):421-5. PubMed ID: 4131429
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin and icterus. Cases in humans].
    Graisely B; Emery JP; Hugues FC; Marche J
    Therapie; 1971; 26(4):655-69. PubMed ID: 5119120
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 6. [Icterus caused by rifampicin and isoniazide].
    Haber I; Hubens H; Buyssens N
    Tijdschr Gastroenterol; 1974; 17(3):165-76. PubMed ID: 4454055
    [No Abstract]   [Full Text] [Related]  

  • 7. [Jaundice and rifampicin].
    Piéron R; Marien C; Jagueux M
    Sem Hop; 1971 Apr; 47(20):1286-95. PubMed ID: 4326532
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiology of jaundice in phthisiology department: responsibility of rifampicin].
    Oury M; Tuchais E; Tuchais M
    Rev Tuberc Pneumol (Paris); 1970; 34(3):415-22. PubMed ID: 5510436
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of rifampicin in tuberculosis].
    Rabukhin AE
    Klin Med (Mosk); 1973 Mar; 51(3):70-6. PubMed ID: 4755485
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced heart failure in advanced pulmonary tuberculosis.
    Daynes G
    S Afr Med J; 1974 Nov; 48(57):2352-3. PubMed ID: 4432186
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
    Burke M; Logan J
    Ir Med J; 1979 Oct; 72(10):430-4. PubMed ID: 500344
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis therapy.
    Lefrock JL; Smith BR
    Am Fam Physician; 1983 Mar; 27(3):261-4. PubMed ID: 6829397
    [No Abstract]   [Full Text] [Related]  

  • 14. Side effects of rifampicin. A clinical study.
    Mattson K
    Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-course chemotherapy. The Arkansas experience.
    Dutt AK; Stead WW
    Chest; 1981 Dec; 80(6):724-7. PubMed ID: 7030655
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
    Hétrick G; Muñoz I; Ras R
    Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood levels of rifampicin in liver diseases.
    Pozzi E; Menghini P
    Int J Clin Pharmacol; 1974 Jul; 10(1):44-9. PubMed ID: 4850803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.